By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282



Company News
Immunomedics (IMMU)'s Breast Cancer Drug Wins Breakthrough Tag from the FDA 2/5/2016 7:33:32 AM
Immunomedics, Inc. (IMMU) Reports Continuing Positive Results With Sacituzumab Govitecan In Heavily Pre-Treated Metastatic Triple-Negative Breast Cancer Patients 12/10/2015 7:09:25 AM
Immunomedics, Inc. (IMMU) Reports Initial Results Of A Phase I First-In-Man Study With IMMU-114 In Hematologic Malignancies 12/7/2015 7:42:24 AM
Immunomedics, Inc. (IMMU) To Participate In The 26th Annual Oppenheimer Healthcare Conference 12/3/2015 8:45:38 AM
Immunomedics, Inc. (IMMU) Announces Voting Results From 2015 Annual Meeting Of Stockholders 12/3/2015 8:39:07 AM
Immunomedics To Present First Clinical Results With Anti-HLA-DR Antibody For Treatment Of Hematologic Malignancies At The 2015 Annual Meeting Of The American Society of Hematology 12/1/2015 10:20:43 AM
Immunomedics, Inc. (IMMU) Reports Improved Progression-Free Survival Results With Sacituzumab Govitecan In Triple-Negative Breast Cancer 11/9/2015 8:13:09 AM
Immunomedics, Inc. (IMMU) Announces Sacituzumab Govitecan Is Synergistic With Chemotherapeutics That Target Cell Division In Triple-Negative Breast Cancer 11/9/2015 7:54:22 AM
Immunomedics, Inc. (IMMU) Announces First Quarter Fiscal 2016 Results And Clinical Program Developments 11/5/2015 6:46:44 AM
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For First Quarter Fiscal 2016 Financial Results 10/29/2015 9:24:59 AM